High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
暂无分享,去创建一个
Mickaël Ohana | Francis Schneider | M. Ohana | H. Merdji | F. Meziani | J. Helms | R. Clere-Jehl | M. Schenck | S. Fafi-Kremer | F. Schneider | Vincent Castelain | Ferhat Meziani | P. Mertes | Julie Helms | Raphaël Clere-Jehl | L. Grunebaum | Paul-Michel Mertes | Samira Fafi-Kremer | Charles Tacquard | François Severac | Ian Leonard-Lorant | Xavier Delabranche | Hamid Merdji | Malika Schenck | Florence Fagot Gandet | Lélia Grunebaum | Eduardo Anglés-Cano | Laurent Sattler | X. Delabranche | L. Sattler | C. Tacquard | F. Séverac | I. Leonard-Lorant | V. Castelain | E. Anglés-Cano | Florence Fagot Gandet
[1] D. Light,et al. Amplified anticoagulant activity of tissue factor-targeted thrombomodulin , 2006, Thrombosis and Haemostasis.
[2] G. Guyatt,et al. Failure of Anticoagulant Thromboprophylaxis: Risk Factors in Medical-Surgical Critically Ill Patients* , 2015, Critical care medicine.
[3] C. Basler. Molecular pathogenesis of viral hemorrhagic fever , 2017, Seminars in Immunopathology.
[4] Arthur S Slutsky,et al. Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .
[5] M. E. Vazquez,et al. Angiogenic and inflammatory markers in acute respiratory distress syndrome and renal injury associated to A/H1N1 virus infection. , 2013, Experimental and molecular pathology.
[6] M. Laffan,et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.
[7] M. Di Nisio,et al. Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity , 2016, Critical Care.
[8] W. Kisiel,et al. Hypoxia/Hypoxemia-Induced activation of the procoagulant pathways and the pathogenesis of ischemia-associated thrombosis. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[9] H. O. Oudemans-van Straaten. Hemostasis and Thrombosis in Continuous Renal Replacement Treatment , 2015, Seminars in Thrombosis & Hemostasis.
[10] E. Seeley. Updates in the management of acute lung injury: a focus on the overlap between AKI and ARDS. , 2013, Advances in chronic kidney disease.
[11] P. Asfar,et al. Microparticles are new biomarkers of septic shock-induced disseminated intravascular coagulopathy , 2013, Intensive Care Medicine.
[12] F B Taylor,et al. Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation , 2001, Thrombosis and Haemostasis.
[13] F. Meziani,et al. Early Detection of Disseminated Intravascular Coagulation During Septic Shock: A Multicenter Prospective Study , 2016, Critical care medicine.
[14] P. Lollar,et al. Involvement of the contact phase and intrinsic pathway in herpes simplex virus‐initiated plasma coagulation , 2010, Journal of thrombosis and haemostasis : JTH.
[15] Bobbie-Jo M. Webb-Robertson,et al. Mechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury , 2013, mBio.
[16] S. Krilis,et al. The pathogenesis of the antiphospholipid syndrome. , 2013, The New England journal of medicine.
[17] Y. Shoenfeld,et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) , 2006, Journal of thrombosis and haemostasis : JTH.
[18] Dengju Li,et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy , 2020, Journal of Thrombosis and Haemostasis.
[19] F. Lemaire,et al. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. , 1990, The New England journal of medicine.
[20] Dengju Li,et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.
[21] C. Sprung,et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock 2012 , 2013, Critical care medicine.
[22] F. Azizi,et al. Nephrogenic acute respiratory distress syndrome: A narrative review on pathophysiology and treatment , 2017, Chinese journal of traumatology = Zhonghua chuang shang za zhi.
[23] A. Falanga,et al. ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 , 2020, Journal of Thrombosis and Haemostasis.
[24] Ezekiel J Emanuel,et al. Fair Allocation of Scarce Medical Resources in the Time of Covid-19. , 2020, The New England journal of medicine.
[25] N. Gupta,et al. The stimulation of thrombosis by hypoxia. , 2019, Thrombosis research.
[26] Ting Yu,et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.
[27] P. D. de Groot,et al. Analysis of thrombotic factors in severe acute respiratory syndrome (SARS) patients , 2006, Thrombosis and Haemostasis.
[28] A. Undas,et al. High detection rates of antithrombin deficiency and antiphospholipid syndrome in outpatients aged over 50 years using the standardized protocol for thrombophilia screening. , 2019, Thrombosis research.
[29] W. Kuebler,et al. The endothelium in hypoxic pulmonary vasoconstriction. , 2017, Journal of applied physiology.
[30] Alan E. Jones,et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 , 2017, Intensive Care Medicine.
[31] T. Martin,et al. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. , 1989, The Journal of clinical investigation.
[32] J. Decruyenaere,et al. Acute Effects of Upright Position on Gas Exchange in Patients With Acute Respiratory Distress Syndrome , 2005, Journal of intensive care medicine.
[33] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[34] M. Yaffe,et al. ISTH interim guidance on recognition and management of coagulopathy in COVID‐19: A comment , 2020, Journal of Thrombosis and Haemostasis.
[35] N. Mackman,et al. Multiple roles of the coagulation protease cascade during virus infection. , 2014, Blood.
[36] T. Desai,et al. Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung. , 1999, American journal of physiology. Lung cellular and molecular physiology.